Literature DB >> 15068939

Hirayama flexion myelopathy: neutral-position MR imaging findings--importance of loss of attachment.

Chi-Jen Chen1, Hui-Ling Hsu, Ying-Chi Tseng, Rong-Kuo Lyu, Chiung-Mei Chen, Ying-Chih Huang, Li-Jen Wang, Yon-Cheong Wong, Lai-Chu See.   

Abstract

PURPOSE: To investigate the sensitivity and specificity of various neutral-position magnetic resonance (MR) imaging findings in the diagnosis of Hirayama flexion myelopathy.
MATERIALS AND METHODS: The neutral-position cervical MR images of 46 patients and 51 control subjects were evaluated for the following findings: localized lower cervical cord atrophy, asymmetric cord flattening, abnormal cervical curvature, loss of attachment (LOA) between the posterior dural sac and subjacent lamina, and noncompressed intramedullary high signal intensity on T2-weighted MR images. The difference in frequency of these findings between the control and patient groups was examined by means of the chi(2) test. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of these MR imaging findings in the diagnosis Hirayama disease were calculated. Multivariate analysis of these findings was also performed.
RESULTS: There was a significant difference in the frequency of these MR imaging findings between the control and patient groups (all comparisons, P </=.002). Among the MR imaging findings, localized lower cervical cord atrophy, asymmetric cord flattening, and LOA had accuracy of more than 80% in identification of the disease. After multivariate analysis, LOA was the only significantly important predictor of the disease, with odds ratio of 716.7 (95% CI: 71.9, 7,145.2). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of LOA were 93.5%, 98.0%, 97.7%, 94.3%, and 95.9%, respectively.
CONCLUSION: LOA from posterior dural sac and subjacent lamina is the most valuable finding in the diagnosis of Hirayama disease at neutral-position MR imaging. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 15068939     DOI: 10.1148/radiol.2311030004

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

1.  Magnetic resonance imaging in Hirayama disease.

Authors:  María Catalina Vargas; Mauricio Castillo
Journal:  J Radiol Case Rep       Date:  2011-03-01

2.  "Sand-watch" spinal cord: a case of inferior cervical spinal cord atrophy.

Authors:  Peter Bede; Ronan Walsh; Andrew J Fagan; Orla Hardiman
Journal:  J Neurol       Date:  2013-11-27       Impact factor: 4.849

3.  Juvenile Muscular Atrophy of a Unilateral Upper Extremity (Hirayama Disease) in a Patient with CHARGE Syndrome.

Authors:  T Yagihashi; K Hatori; K Ishii; C Torii; S Momoshima; T Takahashi; K Kosaki
Journal:  Mol Syndromol       Date:  2010-06-30

4.  Waterskier's Hirayama syndrome.

Authors:  Peter Bede; Arun L W Bokde; Susan C Byrne; Marwa Elamin; Ronan J Walsh; Orla Hardiman
Journal:  J Neurol       Date:  2011-04-19       Impact factor: 4.849

5.  Flexion myelopathy: Hirayama's syndrome.

Authors:  Frank Weber; Uwe M Mauer
Journal:  J Neurol       Date:  2011-08-11       Impact factor: 4.849

6.  Hirayama disease: the importance of adequate flexion MRI for diagnosis.

Authors:  Marinos Kontzialis; Noushin Yahyavi-Firouz-Abadi; Carlos A Zamora
Journal:  Neurol Sci       Date:  2015-04-21       Impact factor: 3.307

7.  'Snake eyes' MRI sign: possible role of cobalt toxicity?

Authors:  Chiara Briani; Mario Cacciavillani; Annamaria Nicolli; Andrea Trevisan; Roberto Gasparotti
Journal:  J Neurol       Date:  2014-12-09       Impact factor: 4.849

8.  Bilateral Upper Limb Weakness.

Authors:  Sivakumar Vadivalagianambi; Venkatraman Indiran
Journal:  Oman Med J       Date:  2018-05

9.  Hirayama disease: a frequently undiagnosed condition with simple inexpensive treatment.

Authors:  Rajesh Verma; Rakesh Lalla; Tushar B Patil; Arvind Gupta
Journal:  BMJ Case Rep       Date:  2012-12-06

10.  Cervical spine MR imaging findings of patients with Hirayama disease in North America: a multisite study.

Authors:  V T Lehman; P H Luetmer; E J Sorenson; R E Carter; V Gupta; G P Fletcher; L S Hu; A L Kotsenas
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.